Luxembourg - Respiratory System Medicine Use
Since 2014, Luxembourg Respiratory System Medicine Use decreased by 0.7% year on year. In 2019, the country was ranked number 19 among other countries in Respiratory System Medicine Use at 71.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Luxembourg is overtaken by Greece, which was ranked number 18 with 72.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Germany with 68.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Norway ranked the highest with 230.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 6% versus 2018. Sweden, Finland and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +10.6% per year, while Slovakia was the worst growing country at -8.4% per year.
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 71.90 |
2018 | 74.20 |
2017 | 70.80 |
2016 | 74.20 |
2015 | 72.40 |
How does Luxembourg rank in Respiratory System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Norway
|
230 | 2019 | +6.0 % | +3.3 % | View data | |
2 |
#2
Sweden
|
206 | 2019 | +6.1 % | +3.9 % | View data | |
18 |
#18
Greece
|
73 | 2019 | +0.8 % | +0.8 % | View data | |
19 |
#19
Luxembourg
|
72 | 2019 | -3.1 % | -0.7 % | View data | |
20 |
#20
Germany
|
68 | 2019 | -1.3 % | -0.7 % | View data |